Return Of The Doc Cuts Threatens Access, Physician-Group Lobby Says, Again
Pending Medicare cuts could mean physician practices would back away from the program, according to a trade group representing these doctor groups
The independent source for health policy research, polling, and news.
59,381 - 59,400 of 112,485 Results
Pending Medicare cuts could mean physician practices would back away from the program, according to a trade group representing these doctor groups
Agweek examines USAID's approach to purchasing food aid. The piece notes USAID Administrator Rajiv Shah's comments from his October 15 remarks at the World Food Prize symposium in Des Moines, Iowa, when he explained that USAID has used $250 million to purchase foodstuffs in developing countries this year.
Nascent accountable care organizations develop with physician input; Harvard Medical School seeks to become a leader in primary care education.
The New York Times reports that as states begin embracing medical marijuana they are also grappling with how they allow or don't allow seniors in nursing homes to use it.
News outlets report on the health care marketplace, including the growing number of surgical centers in Pennsylvania and a new federally qualified community health center in one of Michigan's wealthiest counties.
Today's early morning highlights from the major news organizations, including a report about the reasons behind rising health premiums.
Reuters reports that the developers of a vaginal microbicide gel containing the antiretroviral tenofovir which has been found to reduce "HIV infections in women by 39 percent," said that during meetings last week the U.S. Food and Drug Administration (FDA) granted fast track approval designation to the gel, which expedites the review of drugs by the agency.
The WHO on Tuesday announced a mass polio immunization campaign in 15 African countries targeting a total of 72 million children, Agence France-Presse reports. "Polio has spread again in recent years with cases imported from some of the four endemic nations in Asia and Africa, mainly Nigeria, in a setback to global attempts to eradicate the crippling and sometimes lethal disease," the news service writes (10/26).
Nearly 300 people have died from cholera and 3,612 diagnosed in Haiti's week-old epidemic, Reuters reports, citing numbers from Haitian health authorities. The news service reports that "the U.N., the [Haitian] government, and its foreign aid partners are expecting the disease to spread further in its epidemic phase. They have launched a combined treatment, containment and prevention strategy for the whole country."
A new report (.pdf) highlights concerns about donors, especially from Europe, following through on funding pledges for the G8's $22 billion global food security fund, Business Daily reports (Odhiambo, 10/27).
Candidates are in full campaign mode ahead of midterm elections that will likely spell out how the health law is implemented. Some TV stations have pulled ads because they're false.
Nine southern African countries and donors have gathered in Namibia for the second regional leadership in Health Information Systems (HIS) meeting to discuss "how recipient countries should take ownership of these systems," New Era reports (Sasman, 10/26). Participant countries "will work together to develop country specific strategies to strengthen their national HIS and prepare a country-led action plan," writes the Southern Times. More than 100 delegates representing Angola, Botswana, Lesotho, Mozambique, Namibia, South Africa, Swaziland, Zambia and Zimbabwe are expected to attend from ministries of finance, health, science, information and statistics bureaus (Nashuuta, 10/22).
News outlets report on new rules and pending regulations for the implementation of the new health law.
Marking the 10th anniversary of U.N. Security Council Resolution 1325
A selection of today's opinions and editorials from across the U.S.
States consider an array of health policy topics.
Drugmaker GlaxoSmithKline has agreed to pay $750 million to settle civil and criminal charges that the company for years knowingly sold 20 defective or dangerous drugs manufactured at a contaminated plant.
"The powerful pharmaceutical lobby is pushing back against campaign-trail calls to allow Medicare to negotiate drug prices on behalf of millions of seniors enrolled in Part D," The Hill reports.
News outlets report that gubernatorial candidates in Florida and Minnesota are offering little details about their plans for health spending.
© 2026 KFF